You can buy or sell Elanco and other stocks, options, and ETFs commission-free!
Elanco Animal Health, Inc. engages in the innovation, development, manufacture and market products for companion and food animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded on May 3, 2018 and is headquartered in Greenfield, IN. The listed name for ELAN is Elanco Animal Health Incorporated Common Stock.
Jeffrey N. Simmons
52 Week High
52 Week Low
Edited Transcript of ELAN.N earnings conference call or presentation 24-Feb-21 1:00pm GMT
Q4 2020 Elanco Animal Health Inc Earnings Call Feb 25, 2021 (Thomson StreetEvents) -- Edited Transcript of Elanco Animal Health Inc earnings conference call or
$0.09 per share
$0.12 per share